Two innovative and sustainable projects have been approved for US$20,000 in funding in the 2021 Emory-UQ Collaborative Partnership Research Grant.
Congratulations to the successful applicants:
Child Health Research Centre for GoFAR.
The overarching goal of the proposed collaborative project is to facilitate the dissemination of one of the evidence-based interventions developed at Emory - GoFAR. GoFAR is a unique intervention focused on improving self-regulation and adaptive behaviour abilities for children with FASD. This goal will be achieved through two objectives:
- Emory and UQ staff collaborating on an Australian adaption of the GoFAR intervention materials;
- Co-developing and pilot testing an intervention protocol, which will enable GoFAR to be delivered as a digital health intervention.
Asia Pacific Centre for Neuromodulation (UQ Queensland Brain Institute) for Immunometabolic Biomarkers of Treatment Response in Depression.
An innovative study that brings together experts in psychiatry, behavioural neuroscience, neuroimaging, and biomarker discovery to test a next-generation anti-inflammatory treatment for depression. We will leverage an NIH-funded clinical trial being conducted at Emory University to validate blood and brain-based biomarkers predictive of response and align this with mechanistic animal studies at UQ.
This grant has proven instrumental in supporting efforts in broadening international research and engagement between Emory University and UQ. The next round will continue in 2022.
